Skip to main content

Table 3 Differentially expressed lncRNAs and mRNAs in TB cases with HFYD syndrome

From: Microarray expression profile analysis of mRNAs and long non-coding RNAs in pulmonary tuberculosis with different traditional Chinese medicine syndromes

Seqname

GeneSymbol

P-value

Absolute Fold Change

Associated

Gene

B vs. control

B vs. A

B vs. C

B vs. control

B vs. A

B vs. C

lncRNA

 TCONS_00008415

XLOC_003867

4.72E-02

1.71E-02

3.09E-02

7.24

14.65

10.20

/

 NR_024499

FMR1-AS1

3.45E-02

2.96E-02

3.62E-02

6.64

8.06

7.25

FMR1

 ENST00000510610

RP11-706C16.8

1.95E-04

1.72E-05

2.80E-05

4.57

6.58

6.39

LY6D

 ENST00000521600

PVT1

8.03E-03

1.69E-03

1.88E-02

4.11

5.83

4.95

/

 ENST00000448365

AC078842.4

6.88E-03

3.39E-03

2.75E-03

3.09

3.25

4.11

PTN

 uc021pjm.1

HM358976

2.11E-04

5.85E-08

4.50E-05

−5.46

−4.76

−5.48

/

 ENST00000441029

RP4-553 F4.2

4.27E-05

9.12E-04

4.26E-04

−3.49

−3.27

−4.65

ZNF341

 ENST00000444112

AC005808.3

4.42E-03

2.13E-03

2.58E-02

−2.66

−3.30

−3.08

ZNF217

 TCONS_00004246

XLOC_002087

7.60E-05

1.39E-03

3.01E-04

−4.72

−3.12

−3.88

/

 ENST00000434072

GNG12-AS1

1.72E-03

1.54E-04

1.60E-03

−2.96

−6.46

−2.62

WLS

mRNA

 NM_001916

CYC1

1.26E-04

1.33E-03

1.67E-04

5.39

5.61

7.44

/

 NM_176869

PPA2

1.44E-02

1.67E-02

4.48E-02

2.70

2.02

2.06

/

 ENST00000418434

CASP5

2.61E-02

3.75E-02

1.67E-02

4.29

3.82

5.21

/

 NM_182609

ZNF677

8.52E-03

2.47E-02

2.56E-03

4.35

3.61

5.60

/

 NM_001135086

PRSS41

3.90E-02

1.15E-02

4.07E-02

4.34

9.42

4.54

/

 NM_207174

ABCG1

4.65E-03

2.59E-03

3.68E-02

6.35

8.32

4.40

/

 NM_001101

ACTB

1.95E-03

3.10E-04

1.99E-03

−2.45

−4.22

−3.09

/

 NM_001135575

C6orf228

1.23E-03

1.10E-03

3.89E-03

−6.66

−7.04

−5.13

/

 NM_001166415

EHHADH

3.06E-02

2.25E-02

1.93E-02

−2.79

−2.87

−3.15

/

 NM_152496

MANEAL

2.40E-02

1.28E-02

1.36E-02

−5.78

−8.54

−8.88

/

  1. Twenty of the most significantly differentially expressed lncRNAs and mRNA in TB cases with HFYD syndrome compared to healthy controls and TB cases with PYD syndrome and DQY syndrome
  2. Fold change >2: up-regulated; fold change < -2: down-regulated
  3. A: PYD syndrome; B: HFYD syndrome; C: DQY syndrome